Skip to main content
Premium Trial:

Request an Annual Quote

Reagent Firm Active Motif Acquires TimeLogic

NEW YORK, Aug. 26 (GenomeWeb News) - Active Motif, a Carlsbad, Calif.-based provider of cell biology reagents, said today that it has acquired TimeLogic in a stock deal for an undisclosed price.

 

TimeLogic will move from Crystal Bay, Nev., to Carlsbad and will continue to use the registered trade name "DeCypher" for its accelerated sequence analysis platform, the company said.

 

"By helping connect wet lab science with computational biology methods, we see an excellent opportunity for Active Motif to help TimeLogic's customers," said John Archdeacon, head of R&D for Active Motif, in a statement.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.